Cool Chain Networks Redefine Pharma Cargo Flows
Delta Cargo is expanding its cool chain capabilities across Salt Lake City, Detroit and Minneapolis to support increasingly decentralised pharmaceutical supply chains. It is also strengthening US connections into South America, particularly Brazil, Argentina…
The pharmaceutical cargo market across the United States is entering a more distributed phase, driven by demand for regional resilience, diversified hub strategies and tighter cool chain performance. For passenger airlines with established transatlantic networks, the shift is creating opportunities well beyond traditional gateway operations. Increasingly, cargo strategies are being shaped by where pharmaceutical manufacturers want inventory positioned, how quickly therapies must move across borders, and the need to support onward distribution into Latin America and secondary markets.
For Delta Cargo, that evolution is prompting investment in hub diversification and corridor development. Rather than concentrating pharmaceutical handling through a limited number of gateways, the airline is expanding cool chain capabilities across hubs including Salt Lake City, Detroit and Minneapolis. The strategy reflects a wider market movement towards decentralised healthcare supply chains, particularly as pharmaceutical firms seek to position products closer to consumption markets and reduce exposure to disruption. South American connectivity is also becoming more commercially significant, especially for temperature-sensitive healthcare and cosmetic products moving through US hubs into Brazil, Argentina and Chile.
This story was originally published by Air Cargo Week. Read the full story at Air Cargo Week →




Conversation